Condom policy turnaround welcomed by industry
This article was originally published in Clinica
The low uptake of condoms in campaigns aimed to improve sexual health in the world's Catholic communities could undergo an historic turnaround, if statements by the Church in Spain advocating their importance in preventing HIV transmission gain wider support.
You may also be interested in...
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.